Clinical Trials Browser

Phase 2 × Carcinoma, Intraductal, Noninfiltrating × palbociclib × Clear all

NCT03535506 2025-09-26

WI223281

Phase 2 Terminated

17 enrolled 9 charts

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating